Acadian Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

Acadian Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$116K	Buy	+169,780	New	+$125K	﹤0.01%	1712
2025 Q2	–	Sell	-30,173	Closed	-$17K	–	1836
2025 Q1	$17K	Buy	+30,173	New	+$29.8K	﹤0.01%	1543
2024 Q4	–	Sell	-12,564	Closed	-$24K	–	2163
2024 Q3	$24K	Buy	12,564 +702	+6%	+$1.98K	﹤0.01%	1954
2024 Q2	$36K	Sell	11,862 -167,270	-93%	-$691K	﹤0.01%	1634
2024 Q1	$936K	Sell	179,132 -115,373	-39%	-$552K	﹤0.01%	861
2023 Q4	$952K	Buy	294,505 +190,436	+183%	+$411K	﹤0.01%	874
2023 Q3	$263K	Buy	104,069 +86,769	+502%	+$363K	﹤0.01%	1150
2023 Q2	$101K	Sell	17,300 -11,620	-40%	-$67.5K	﹤0.01%	1400
2023 Q1	$81K	Buy	+28,920	New	+$81.3K	﹤0.01%	1435

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management's TNYA Position: Q1 2026 in Review

Acadian Asset Management opened a new position in Tenaya Therapeutics (TNYA) in Q1 2026: 169,780 shares worth $116K. The stake represents ﹤0.01% of the portfolio and ranks #1712 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in TNYA as recently as Q1 2025.

Acadian Asset Management first reported a position in TNYA in Q1 2023 and has held it in 9 quarters since. The position peaked at $952K in Q4 2023. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Acadian Asset Management held 169,780 shares of Tenaya Therapeutics worth $116K as of Q1 2026.
Tenaya Therapeutics was a new Acadian Asset Management position in Q1 2026.
Tenaya Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1712 holding.
Acadian Asset Management first reported a position in Tenaya Therapeutics in Q1 2023 and has held it in 9 quarters since.
Acadian Asset Management's Tenaya Therapeutics position peaked at $952K in Q4 2023.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.